Evaluation of the Efficacy and Safety of Laxymig® as Prophylactic Treatment in Patients With Migraine

Clinical trial NCT00334178 · COMPLETED

Trial details

NCT number: NCT00334178
Sponsor: Lotus Pharmaceutical
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Migraine With Aura Migraine Without Aura

Start date: 2004-11-01
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.